Genetic Evolution of Japanese Encephalitis Virus

Ching-Kai Chuang,Wei-June Chen,Wei-June Che

DOI: https://doi.org/10.5772/21252

2011-09-30

Abstract:Genetic Evolution of Japanese Encephalitis Virus | InTechOpen, Published on: 2011-09-30. Authors: Ching-Kai Chuang and Wei-June Chen

What problem does this paper attempt to address?

Genomic Characteristics and E Protein Bioinformatics Analysis of JEV Isolates from South China from 2011 to 2018

Yawei Sun,Hongxing Ding,Feifan Zhao,Quanhui Yan,Yuwan Li,Xinni Niu,Weijun Zeng,Keke Wu,Bing Ling,Shuangqi Fan,Mingqiu Zhao,Lin Yi,Jinding Chen

DOI: https://doi.org/10.3390/vaccines10081303

2022-08-12

Abstract:Japanese encephalitis is a mosquito-borne zoonotic epidemic caused by the Japanese encephalitis virus (JEV). JEV is not only the leading cause of Asian viral encephalitis, but also one of the leading causes of viral encephalitis worldwide. To understand the genetic evolution and E protein characteristics of JEV, 263 suspected porcine JE samples collected from South China from 2011 to 2018 were inspected. It was found that 78 aborted porcine fetuses were JEV-nucleic-acid-positive, with a positive rate of 29.7%. Furthermore, four JEV variants were isolated from JEV-nucleic-acid-positive materials, namely, CH/GD2011/2011, CH/GD2014/2014, CH/GD2015/2015, and CH/GD2018/2018. The cell culture and virus titer determination of four JEV isolates showed that four JEV isolates could proliferate stably in Vero cells, and the virus titer was as high as 108.5 TCID 50/mL. The whole-genome sequences of four JEV isolates were sequenced. Based on the phylogenetic analysis of the JEV E gene and whole genome, it was found that CH/GD2011/2011 and CH/GD2015/2015 belonged to the GIII type, while CH/GD2014/2014 and CH/GD2018/2018 belonged to the GI type, which was significantly different from that of the JEV classical strain CH/BJ-1/1995. Bioinformatics tools were used to analyze the E protein phosphorylation site, glycosylation site, B cell antigen epitope, and modeled 3D structures of E protein in four JEV isolates. The analysis of the prevalence of JEV and the biological function of E protein can provide a theoretical basis for the prevention and control of JEV and the design of antiviral drugs.
Comparative genomics of Japanese encephalitis virus shows low rates of recombination and a small subset of codon positions under episodic diversifying selection

Mark Sistrom,Hannah Andrews,Danielle L. Edwards

DOI: https://doi.org/10.1371/journal.pntd.0011459

2024-02-01

PLoS Neglected Tropical Diseases

Abstract:Orthoflavivirus japonicum (JEV) is the dominant cause of viral encephalitis in the Asian region with 100,000 cases and 25,000 deaths reported annually. The genome is comprised of a single polyprotein that encodes three structural and seven non-structural proteins. We collated a dataset of 349 complete genomes from a number of public databases, and analysed the data for recombination, evolutionary selection and phylogenetic structure. There are low rates of recombination in JEV, subsequently recombination is not a major evolutionary force shaping JEV. We found a strong overall signal of purifying selection in the genome, which is the main force affecting the evolutionary dynamics in JEV. There are also a small number of genomic sites under episodic diversifying selection, especially in the envelope protein and non-structural proteins 3 and 5. Overall, these results support previous analyses of JEV evolutionary genomics and provide additional insight into the evolutionary processes shaping the distribution and adaptation of this important pathogenic arbovirus. This comparative study of Japanese Encephalitis Virus is the largest genomic analysis of the virus to date. We undertake a suite of analyses to investigate phylogenetic relationships, rates of recombination and patterns of genomic selection. We show that recombination is not a significant driver of evolution in JEV, demonstrate support for previous phylogenetic reconstructions of the virus, and find a number of sites across the genome under episodic diversifying selection. These adaptive hotspots of evolution serve as key genomic points for the adaptive evolution of this important vector borne pathogen.

tropical medicine,parasitology
Current Advances in Japanese Encephalitis Virus Drug Development

Jiao Guo,Yunqi Mi,Yan Guo,Yang Bai,Meihua Wang,Wei Wang,Yang Wang

DOI: https://doi.org/10.3390/v16020202

2024-01-29

Viruses

Abstract:Japanese encephalitis virus (JEV) belongs to the Flaviviridae family and is a representative mosquito-borne flavivirus responsible for acute encephalitis and meningitis in humans. Despite the availability of vaccines, JEV remains a major public health threat with the potential to spread globally. According to the World Health Organization (WHO), there are an estimated 69,000 cases of JE each year, and this figure is probably an underestimate. The majority of JE victims are children in endemic areas, and almost half of the surviving patients have motor or cognitive sequelae. Thus, the absence of a clinically approved drug for the treatment of JE defines an urgent medical need. Recently, several promising and potential drug candidates were reported through drug repurposing studies, high-throughput drug library screening, and de novo design. This review focuses on the historical aspects of JEV, the biology of JEV replication, targets for therapeutic strategies, a target product profile, and drug development initiatives.

virology
Japanese encephalitis virus: An overview

Qiuyang Li,Xiaoling Cheng,Min Luo,Jinrong Shi

DOI: https://doi.org/10.4103/JVBD.JVBD_49_24

2024-10-05

Abstract:Japanese encephalitis (JE) is a mosquito-borne infectious disease caused by the Japanese encephalitis virus (JEV), posing a substantial threat to human health and property safety. Until now, there has been a lack of specific therapeutic options for treating JEV infections. In this review article, we provide a comprehensive discussion of JEV's characteristics, diagnostic methodologies, vaccine development efforts, and potential anti-JEV pharmaceuticals to provide insights and references that could be used to inform and enhance strategies for the prevention and control of Japanese encephalitis.
[Japanese Encephalitis Virus with Genotype I is Predominant in Sichuan Province].

Jia-Ke Zhang,Shi-Hua Lin,Xing-Yu Zhou,Dan-Lin Chen,Shi-Hong Fu,Xue-Cheng Liu,Wei Yuan,Yi-Ou Cao,Huan-Yu Wang,Wei Li,Mei Hu,Guo-Dong Liang

DOI: https://doi.org/10.3760/cma.j.issn.1003-9279.2012.04.001

2012-01-01

Abstract:OBJECTIVE:To understand molecular characteristics of Japanese encephalitis virus (JEV) isolated from the major Japanese encephalitis epidemic areas in Sichuan Province, and to provide the foundation for JEV prevention.METHODS:13 JEV strains were isolated from mosquitoes in Sichuan during 2007-2010, E genes and preM genes were sequenced and phylogenetic analyses were performed using MEGA5 molecular software.RESULTS:Phylogenetic analysis indicated that all 13 JEV strains from Sichuan belonged to genotype I, homologies at nucleotide level and deduced amino acid level in PreM gene were 97%-100% and 98.7%-100%, and 97.8%-99.9% and 99.6%-100% in E gene, respectively. Homologies at nucleotide level and deduced amino acid level in PreM gene between 13 JEV strains and JEV isolated in 2004 in Sichuan were 96.2%-99.1% and 97.5%-98.7%, and were 97.7%-99.6% and 98. 6%-100% in E gene, respectively. By comparison with vaacine strains P3 and SA14-14-2, homologies at nucleotide level and deduced amino acid level were 84.1%-85.8% and 93.7%-96.2% in PreM gene, and were 87.6%-88.3% and 97%-97.8% in E gene, respectively. The neurovirulence-related 8 amino acid sites encode by E gene remained unchanged in 13 JEV strains.CONCLUSION:JEV with genotype I predominated in Sichuan, nucleotide sequences and deduced amino acid sequences in PreM gene and E gene were highly conserved, key neurovirulence-rerlated sites remained unchanged. It suggested currently used vaccine is still capable of preventing JEV infection.
Review of climate, landscape, and viral genetics as drivers of the Japanese encephalitis virus ecology

Guillaume Le Flohic,Vincent Porphyre,Philippe Barbazan,Jean-Paul Gonzalez

DOI: https://doi.org/10.1371/journal.pntd.0002208

2013-09-12

Abstract:The Japanese encephalitis virus (JEV), an arthropod-born Flavivirus, is the major cause of viral encephalitis, responsible for 10,000-15,000 deaths each year, yet is a neglected tropical disease. Since the JEV distribution area has been large and continuously extending toward new Asian and Australasian regions, it is considered an emerging and reemerging pathogen. Despite large effective immunization campaigns, Japanese encephalitis remains a disease of global health concern. JEV zoonotic transmission cycles may be either wild or domestic: the first involves wading birds as wild amplifying hosts; the second involves pigs as the main domestic amplifying hosts. Culex mosquito species, especially Cx. tritaeniorhynchus, are the main competent vectors. Although five JEV genotypes circulate, neither clear-cut genotype-phenotype relationship nor clear variations in genotype fitness to hosts or vectors have been identified. Instead, the molecular epidemiology appears highly dependent on vectors, hosts' biology, and on a set of environmental factors. At global scale, climate, land cover, and land use, otherwise strongly dependent on human activities, affect the abundance of JEV vectors, and of wild and domestic hosts. Chiefly, the increase of rice-cultivated surface, intensively used by wading birds, and of pig production in Asia has provided a high availability of resources to mosquito vectors, enhancing the JEV maintenance, amplification, and transmission. At fine scale, the characteristics (density, size, spatial arrangement) of three landscape elements (paddy fields, pig farms, human habitations) facilitate or impede movement of vectors, then determine how the JEV interacts with hosts and vectors and ultimately the infection risk to humans. If the JEV is introduced in a favorable landscape, either by live infected animals or by vectors, then the virus can emerge and become a major threat for human health. Multidisciplinary research is essential to shed light on the biological mechanisms involved in the emergence, spread, reemergence, and genotypic changes of JEV.
A Bibliometric Analysis of Global Research on Japanese Encephalitis From 1934 to 2020

Chongxiao Xu,Weijia Zhang,Yuefeng Pan,Guowei Wang,Qikai Yin,Shihong Fu,Fan Li,Ying He,Songtao Xu,Zhenhai Wang,Guodong Liang,Kai Nie,Huanyu Wang

DOI: https://doi.org/10.3389/fcimb.2022.833701

IF: 6.073

2022-01-27

Frontiers in Cellular and Infection Microbiology

Abstract:Japanese encephalitis (JE) is a mosquito-borne disease caused by the Japanese encephalitis virus (JEV). The disease is mainly an epidemic in Asia and has been studied for nearly 90 years. To evaluate the research trends of JE, 3,023 English publications between 1934 and 2020 were retrieved and analyzed from the Web of Science database using indicators for publication, country or territory, citation, journal, author and affiliation, keyword co-occurrence cluster, and strongest citation bursts detection. The results of the bibliometric analysis and the visualization tools show that the number of annual publications on JE has been increasing. JE has been continuously studied in the USA and also many Asian countries, such as Japan, China, India, and South Korea; however, only a few publications have high citations. The main research groups of JE in the last 5 years were in China, Japan, and the UK. The keyword co-occurrence analysis and the strongest citation bursts detection revealed that most studies focused on the pathogenic mechanism of JEV, control of outbreaks, and immunization with JE vaccine. The research maps on JE obtained by our analysis are expected to help researchers effectively explore the disease.

immunology,microbiology
Near-atomic structure of Japanese encephalitis virus reveals critical determinants of virulence and stability

Xiangxi Wang,Shi-Hua Li,Ling Zhu,Qing-Gong Nian,Shuai Yuan,Qiang Gao,Zhongyu Hu,Qing Ye,Xiao-Feng Li,Dong-Yang Xie,Neil Shaw,Junzhi Wang,Thomas S. Walter,Juha T. Huiskonen,Elizabeth E. Fry,Cheng-Feng Qin,David I. Stuart,Zihe Rao

DOI: https://doi.org/10.1038/s41467-017-00024-6

IF: 16.6

2017-01-01

Nature Communications

Abstract:Although several different flaviviruses may cause encephalitis, Japanese encephalitis virus is the most significant, being responsible for thousands of deaths each year in Asia. The structural and molecular basis of this encephalitis is not fully understood. Here, we report the cryo-electron microscopy structure of mature Japanese encephalitis virus at near-atomic resolution, which reveals an unusual “hole” on the surface, surrounded by five encephalitic-specific motifs implicated in receptor binding. Glu138 of E, which is highly conserved in encephalitic flaviviruses, maps onto one of these motifs and is essential for binding to neuroblastoma cells, with the E138K mutation abrogating the neurovirulence and neuroinvasiveness of Japanese encephalitis virus in mice. We also identify structural elements modulating viral stability, notably Gln264 of E, which, when replaced by His264 strengthens a hydrogen-bonding network, leading to a more stable virus. These studies unveil determinants of neurovirulence and stability in Japanese encephalitis virus, opening up new avenues for therapeutic interventions against neurotropic flaviviruses.
Japanese encephalitis virus invasion of cell: allies and alleys

Minu Nain,Malik Z Abdin,Manjula Kalia,Sudhanshu Vrati,Malik Z. Abdin

DOI: https://doi.org/10.1002/rmv.1868

2015-12-23

Reviews in Medical Virology

Abstract:The mosquito-borne flavivirus, Japanese encephalitis virus (JEV), is the leading cause of virus-induced encephalitis globally and a major public health concern of several countries in Southeast Asia, with the potential to become a global pathogen. The virus is neurotropic, and the disease ranges from mild fever to severe hemorrhagic and encephalitic manifestations and death. The early steps of the virus life cycle, binding, and entry into the cell are crucial determinants of infection and are potential targets for the development of antiviral therapies. JEV can infect multiple cell types; however, the key receptor molecule(s) still remains elusive. JEV also has the capacity to utilize multiple endocytic pathways for entry into cells of different lineages. This review not only gives a comprehensive update on what is known about the virus attachment and receptor system (allies) and the endocytic pathways (alleys) exploited by the virus to gain entry into the cell and establish infection but also discusses crucial unresolved issues. We also highlight common themes and key differences between JEV and other flaviviruses in these contexts.

virology
Envelope domain III E324, E351, and E380 mutations lever adaptive evolution of DENV-1 genotype I

Tao Jiang,Chenxiao Huang,Qianqian Ruan,Xiaorong Huang,Chumin Liang,Zhiqiang Chen,Xi Yu,Yihao Peng,Zheng Liu,Gong Cheng,Jianfeng Dai,Jiufeng Sun

DOI: https://doi.org/10.1128/jvi.01183-24

2024-09-04

Abstract:Dengue virus (DENV) gains genetic mutations during continuous transmission and evolution, making the virus more adaptive and virulent. The clade of DENV-1 genotype I has expanded and become the predominant genotype in Asia and the Pacific areas, but the underlying mechanisms are unclear. A combined analysis of nonsynonymous mutations in domain III of the envelope protein and their biological effects on virus pathogenesis and transmission was evaluated. Phylogenetic analyses found three nonsynonymous mutations (V324I, V351L, and V380I) in domain III of the envelope protein, which emerged in 1970s-1990s and stably inherited and expanded in contemporary strains after 2000. We generated reverse-mutated viruses (I324V, L351V, and I380V) based on an infectious clone of an epidemic DENV-1 strain (NIID02-20), and the results suggested that the infectivity of the contemporary epidemic virus (wild type, WT) has increased compared to the reverse mutant viruses in mammalian hosts but not mosquito vectors. The WT virus showed a higher binding affinity to host cells and increased virion stability. In addition, weaker immunogenicity and higher resistance to neutralizing antibodies of the WT virus indicated a trend of immune escape. The data suggested that nonsynonymous mutations of the E protein (V324I, V351L, and V380I) promote infectivity and immune evasion of DENV-1 genotype I, which may facilitate its onward transmission on a global scale. Importance: We provide evidence that minor sequence variation among dengue virus (DENV) strains can result in increased adaptability and virulence, impacting both the biology of the virus and the antiviral immune response. The genetic mutations of DENV-1 gained during continuous transmission and evolution will offer new clues for the design of novel vaccines against flaviviruses.
Genetic Analysis of Strains of Japanese Encephalitis Virus Isolated from Swine in Central China

Jian-Ming Fan,Jun Luo,Lu Chen,Man Teng,Dan Bu,Fang-Yu Wang,Li Wang,Chuan-Qing Wang,Gai-Ping Zhang

DOI: https://doi.org/10.1007/s11262-010-0464-9

2010-01-01

Virus Genes

Abstract:In this study, four strains of Japanese Encephalitis Virus (JEV) were isolated from the cerebrospinal fluid of aborted fetuses or stillborn piglets collected randomly from a number of piggeries in central China. The E genes were cloned by RT–PCR and sequenced. Phylogenetic analysis was performed with 48 JEV isolates previously reported in China and other countries, and showed that all four isolates can be classified into the subcluster of genotype III. The results strongly suggest that the genotype III of JEV is the major variant currently circulating in the swinery of central China.
Virulence and Cross-Protection Conferred by an Attenuated Genotype I-Based Chimeric Japanese Encephalitis Virus Strain Harboring the E Protein of Genotype V in Mice

Qiqi Xia,Yan Zhang,Yang Yang,Xiaochun Ma,Zhixin Guan,Junjie Zhang,Zongjie Li,Ke Liu,Beibei Li,Donghua Shao,Yafeng Qiu,Jianchao Wei,Zhiyong Ma

DOI: https://doi.org/10.1128/spectrum.01990-22

IF: 3.7

2022-10-28

Microbiology Spectrum

Abstract:The GV JEV showed an increase in epidemic areas, which exhibited higher pathogenicity in mice than the prevalent GI and GIII strains. We replaced a recombinant chimeric GI-GV JEV (JEV-GI/V) strain to determine the role of the structural proteins in virulence and cross-protection.

microbiology
Main Factors Influencing the Efficient Propagation of Virulent or Attenuated Strains of Japanese Encephalitis Virus in BHK-21 Cells

Man Teng,Jun Luo,Guang-Xu Xing,Na Cheng,Yan-Yan Yang,Rui-Guang Deng,Gai-Ping Zhang

DOI: https://doi.org/10.1007/s13337-012-0094-z

2012-01-01

Abstract:Japanese encephalitis virus (JEV) causes severe viral encephalitis in humans and some other mammalian animals. Highly efficient culture of the virus is critical for antigen preparation, vaccine production and other basic researches. We have investigated the influence of a number of variables such as the strain virulence, the state of the host cells, medium composition, infection method and others on the proliferation of distinct JEV strains in BHK-21 cells. The results showed that two distinct strategies are needed for the propagation of virulent or attenuated JEV strains. The most critical variables were the method of infection, and especially the density of the host cell. Our studies indicate the general approaches to the in vitro culture of other JEV strains using BHK-21 cell line.
A Molecularly Cloned, Live-Attenuated Japanese Encephalitis Vaccine SA14-14-2 Virus: a Conserved Single Amino Acid in the Ij Hairpin of the Viral E Glycoprotein Determines Neurovirulence in Mice.

Sang-Im Yun,Byung-Hak Song,Jin-Kyoung Kim,Gil-Nam Yun,Eun-Young Lee,Long Li,Richard J Kuhn,Michael G Rossmann,John D Morrey,Young-Min Lee

DOI: https://doi.org/10.1371/journal.ppat.1004290

IF: 7.464

2014-01-01

PLoS Pathogens

Abstract:Japanese encephalitis virus (JEV), a mosquito-borne flavivirus that causes fatal neurological disease in humans, is one of the most important emerging pathogens of public health significance. JEV represents the JE serogroup, which also includes West Nile, Murray Valley encephalitis, and St. Louis encephalitis viruses. Within this serogroup, JEV is a vaccine-preventable pathogen, but the molecular basis of its neurovirulence remains unknown. Here, we constructed an infectious cDNA of the most widely used live-attenuated JE vaccine, SA14-14-2, and rescued from the cDNA a molecularly cloned virus, SA14-14-2MCV, which displayed in vitro growth properties and in vivo attenuation phenotypes identical to those of its parent, SA14-14-2. To elucidate the molecular mechanism of neurovirulence, we selected three independent, highly neurovirulent variants (LD50, <1.5 PFU) from SA14-14-2MCV (LD50, >1.5×105 PFU) by serial intracerebral passage in mice. Complete genome sequence comparison revealed a total of eight point mutations, with a common single G1708→A substitution replacing a Gly with Glu at position 244 of the viral E glycoprotein. Using our infectious SA14-14-2 cDNA technology, we showed that this single Gly-to-Glu change at E-244 is sufficient to confer lethal neurovirulence in mice, including rapid development of viral spread and tissue inflammation in the central nervous system. Comprehensive site-directed mutagenesis of E-244, coupled with homology-based structure modeling, demonstrated a novel essential regulatory role in JEV neurovirulence for E-244, within the ij hairpin of the E dimerization domain. In both mouse and human neuronal cells, we further showed that the E-244 mutation altered JEV infectivity in vitro, in direct correlation with the level of neurovirulence in vivo, but had no significant impact on viral RNA replication. Our results provide a crucial step toward developing novel therapeutic and preventive strategies against JEV and possibly other encephalitic flaviviruses.
Japanese Encephalitis: Risk of Emergence in the United States and the Resulting Impact

Thomas P Monath

DOI: https://doi.org/10.3390/v16010054

2023-12-28

Viruses

Abstract:Japanese encephalitis virus is a mosquito-borne member of the Flaviviridae family. JEV is the leading cause of viral encephalitis in Asia and is characterized by encephalitis, high lethality, and neurological sequelae in survivors. The virus also causes severe disease in swine, which are an amplifying host in the transmission cycle, and in horses. US agricultural authorities have recently recognized the threat to the swine industry and initiated preparedness activities. Other mosquito-borne viruses exotic to the Western Hemisphere have been introduced and established in recent years, including West Nile, Zika, and chikungunya viruses, and JEV has recently invaded continental Australia for the first time. These events amply illustrate the potential threat of JEV to US health security. Susceptible indigenous mosquito vectors, birds, feral and domestic pigs, and possibly bats, constitute the receptive ecological ingredients for the spread of JEV in the US. Fortunately, unlike the other virus invaders mentioned above, an inactivated whole virus JE vaccine (IXIARO®) has been approved by the US Food and Drug Administration for human use in advance of a public health emergency, but there is no veterinary vaccine. This paper describes the risks and potential consequences of the introduction of JEV into the US, the need to integrate planning for such an event in public health policy, and the requirement for additional countermeasures, including antiviral drugs and an improved single dose vaccine that elicits durable immunity in both humans and livestock.
Efficacy of genotype-matched vaccine against re-emerging genotype V Japanese encephalitis virus

Jae-Deog Kim,Ah-Ra Lee,Dah-Hyun Moon,Young-Uk Chung,Su-Yeon Hong,Hyo Je Cho,Tae Hyun Kang,Yo Han Jang,Myung Hyun Sohn,Baik-Lin Seong,Sang-Uk Seo

DOI: https://doi.org/10.1080/22221751.2024.2343910

2024-05-01

Emerging Microbes & Infections

Abstract:Japanese encephalitis (JE), caused by the Japanese encephalitis virus (JEV), is a highly threatening disease with no specific treatment. Fortunately, the development of vaccines has enabled effective defense against JE. However, re-emerging genotype V (GV) JEV poses a challenge as current vaccines are genotype III (GIII)-based and provide suboptimal protection. Given the isolation of GV JEVs from Malaysia, China, and the Republic of Korea, there is a concern about the potential for a broader outbreak. Under the hypothesis that a GV-based vaccine is necessary for effective defense against GV JEV, we developed a pentameric recombinant antigen using cholera toxin B as a scaffold and mucosal adjuvant, which was conjugated with the E protein domain III of GV by genetic fusion. This GV-based vaccine antigen induced a more effective immune response in mice against GV JEV isolates compared to GIII-based antigen and efficiently protected animals from lethal challenges. Furthermore, a bivalent vaccine approach, inoculating simultaneously with GIII- and GV-based antigens, showed protective efficacy against both GIII and GV JEVs. This strategy presents a promising avenue for comprehensive protection in regions facing the threat of diverse JEV genotypes, including both prevalent GIII and GI as well as emerging GV strains.

immunology,infectious diseases,microbiology
Insights into the Pathogenesis and Development of Recombinant Japanese Encephalitis Virus Genotype 3 as a Vaccine

Jae-Yeon Park,Hye-Mi Lee,Sung-Hoon Jun,Wataru Kamitani,Onnuri Kim,Hyun-Jin Shin

DOI: https://doi.org/10.3390/vaccines12060597

2024-05-31

Vaccines

Abstract:Japanese encephalitis virus (JEV), a flavivirus transmitted by mosquitoes, has caused epidemics and severe neurological diseases in Asian countries. In this study, we developed a cDNA infectious clone, pBAC JYJEV3, of the JEV genotype 3 strain (EF571853.1) using a bacterial artificial chromosome (BAC) vector. The constructed infectious clone was transfected into Vero cells, where it exhibited infectivity and induced cytopathic effects akin to those of the parent virus. Confocal microscopy confirmed the expression of the JEV envelope protein. Comparative analysis of growth kinetics revealed similar replication dynamics between the parental and recombinant viruses, with peak titers observed 72 h post-infection (hpi). Furthermore, plaque assays demonstrated comparable plaque sizes and morphologies between the viruses. Cryo-electron microscopy confirmed the production of recombinant virus particles with a morphology identical to that of the parent virus. Immunization studies in mice using inactivated parental and recombinant viruses revealed robust IgG responses, with neutralizing antibody production increasing over time. These results showcase the successful generation and characterization of a recombinant JEV3 virus and provide a platform for further investigations into JEV pathogenesis and vaccine development.

immunology,medicine, research & experimental
Molecular Detection and Genetic Characterization of Japanese Encephalitis Virus in Animals from 11 Provinces in China

Guanyu Zhao,Yan Gao,Ning Shi,Shiheng Zhang,Pengpeng Xiao,Jiaqi Zhang,Changzhan Xie,Zhuo Ha,Sheng Feng,Chenghui Li,Xuancheng Zhang,Yubiao Xie,Ning Yu,He Zhang,Junlong Bi,Ningyi Jin

DOI: https://doi.org/10.3390/v15030625

2023-02-25

Viruses

Abstract:Japanese encephalitis virus (JEV), which uses a mosquito primary vector and swine as a reservoir host, poses a significant risk to human and animal health. JEV can be detected in cattle, goats and dogs. A molecular epidemiological survey of JEV was conducted in 3105 mammals from five species, swine, fox, racoon dog, yak and goat, and 17,300 mosquitoes from 11 Chinese provinces. JEV was detected in pigs from Heilongjiang (12/328, 3.66%), Jilin (17/642, 2.65%), Shandong (14/832, 1.68%), Guangxi (8/278, 2.88%) and Inner Mongolia (9/952, 0.94%); in goats (1/51, 1.96%) from Tibet; and mosquitoes (6/131, 4.58%) from Yunnan. A total of 13 JEV envelope (E) gene sequences were amplified in pigs from Heilongjiang (5/13), Jilin (2/13) and Guangxi (6/13). Swine had the highest JEV infection rate of any animal species, and the highest infection rates were found in Heilongjiang. Phylogenetic analysis indicated that the predominant strain in Northern China was genotype I. Mutations were found at residues 76, 95, 123, 138, 244, 474 and 475 of E protein but all sequences had predicted glycosylation sites at ′N154. Three strains lacked the threonine 76 phosphorylation site from non-specific (unsp) and protein kinase G (PKG) site predictions; one lacked the threonine 186 phosphorylation site from protein kinase II (CKII) prediction; and one lacked the tyrosine 90 phosphorylation site from epidermal growth factor receptor (EGFR) prediction. The aim of the current study was to contribute to JEV prevention and control through the characterization of its molecular epidemiology and prediction of functional changes due to E-protein mutations.

virology
Characterization of genotype V Japanese encephalitis virus isolates from Republic of Korea

Ah-Ra Lee,Sang-Hyun Kim,Su-Yeon Hong,Sang-Ho Lee,Jae Sang Oh,Kyung Yong Lee,Seong-Jun Kim,Tomohiro Ishikawa,Sang-Mu Shim,Hee Il Lee,Sang-Uk Seo

DOI: https://doi.org/10.1080/22221751.2024.2362392

2024-06-12

Emerging Microbes & Infections

Abstract:Japanese encephalitis (JE), caused by the Japanese encephalitis virus (JEV) infection, continues to pose significant public health challenges worldwide despite efficient vaccines. The virus is classified into five genotypes, among which genotype V (GV) was not detected for a long period after its initial isolation in 1952, until reports emerged from China and the Republic of Korea (ROK) since 2009. The characteristics of the virus are crucial in estimating its potential epidemiological impact. However, characterization of GV JEVs has so far been limited to two strains: Muar, the original isolate, and XZ0934, isolated in China. Two additional ROK GV JEV isolates, NCCP 43279 and NCCP 43413, are currently available, but their characteristics have not been explored. Our phylogenetic analysis revealed that GV virus sequences from the ROK segregate into two clades. NCCP 43279 and NCCP 43413 belong to different clades and exhibit distinct in vitro phenotypes. NCCP 43279 forms larger plaques but demonstrates inefficient propagation in cell culture compared to NCCP 43413. In vivo , NCCP 43279 induces higher morbidity and mortality in mice than NCCP 43413. Notably, NCCP 43279 shows more severe blood–brain barrier damage, suggesting superior brain invasion capabilities. Consistent with its higher virulence, NCCP 43279 displays more pronounced histopathological and immunopathological outcomes. In conclusion, our study confirms that the two ROK isolates are not only classified into different clades but also exhibit distinct in vitro and in vivo characteristics.

immunology,infectious diseases,microbiology
Molecular Characterization of Japanese Encephalitis Viruses Circulating in Pigs and Mosquitoes on Pig Farms in the Chinese Province of Henan

Man Teng,Jun Luo,Jian-Ming Fan,Lu Chen,Xing-Tao Wang,Wu Yao,Chuan-Qing Wang,Gai-Ping Zhang

DOI: https://doi.org/10.1007/s11262-012-0813-y

2012-01-01

Virus Genes

Abstract:Since the first Chinese case report of Japanese encephalitis, Japanese encephalitis virus (JEV) has circulated in China for at least 60 years. Even though pigs play a critical role in the JEV transmission cycle information on the prevalence of JEV in pigs has not been investigated in China. As the central Chinese province of Henan has the largest human population in China, a history of serious JEV and is the largest pig producing province it was chosen for this study. We have found that currently natural infection with JEV in pigs and mosquitoes is prevalent and both genotypes 1 and 3 co-circulate in pigs and mosquitoes in central China. Phylogenetic analysis showed that all of the newly obtained pig-derived JEV isolates are more closely related to isolates from the 1950s to 1960s than to those recently isolated from humans and mosquitoes. Further analyses based on all the previous reported Chinese isolates indicates that presently genotype 3 JEV is the predominant genotype in pigs but genotype 1 JEV is emerging and spreading rapidly in recent years. Our study provides information for understanding the current epidemiology of JEV in China and suggests possible measures applicable to the further control of JEV.

Genetic Evolution of Japanese Encephalitis Virus

Genomic Characteristics and E Protein Bioinformatics Analysis of JEV Isolates from South China from 2011 to 2018

Comparative genomics of Japanese encephalitis virus shows low rates of recombination and a small subset of codon positions under episodic diversifying selection

Current Advances in Japanese Encephalitis Virus Drug Development

Japanese encephalitis virus: An overview

[Japanese Encephalitis Virus with Genotype I is Predominant in Sichuan Province].

Review of climate, landscape, and viral genetics as drivers of the Japanese encephalitis virus ecology

A Bibliometric Analysis of Global Research on Japanese Encephalitis From 1934 to 2020

Near-atomic structure of Japanese encephalitis virus reveals critical determinants of virulence and stability

Japanese encephalitis virus invasion of cell: allies and alleys

Envelope domain III E324, E351, and E380 mutations lever adaptive evolution of DENV-1 genotype I

Genetic Analysis of Strains of Japanese Encephalitis Virus Isolated from Swine in Central China

Virulence and Cross-Protection Conferred by an Attenuated Genotype I-Based Chimeric Japanese Encephalitis Virus Strain Harboring the E Protein of Genotype V in Mice

Main Factors Influencing the Efficient Propagation of Virulent or Attenuated Strains of Japanese Encephalitis Virus in BHK-21 Cells

A Molecularly Cloned, Live-Attenuated Japanese Encephalitis Vaccine SA14-14-2 Virus: a Conserved Single Amino Acid in the Ij Hairpin of the Viral E Glycoprotein Determines Neurovirulence in Mice.

Japanese Encephalitis: Risk of Emergence in the United States and the Resulting Impact

Efficacy of genotype-matched vaccine against re-emerging genotype V Japanese encephalitis virus

Insights into the Pathogenesis and Development of Recombinant Japanese Encephalitis Virus Genotype 3 as a Vaccine

Molecular Detection and Genetic Characterization of Japanese Encephalitis Virus in Animals from 11 Provinces in China

Characterization of genotype V Japanese encephalitis virus isolates from Republic of Korea

Molecular Characterization of Japanese Encephalitis Viruses Circulating in Pigs and Mosquitoes on Pig Farms in the Chinese Province of Henan